Extensive evidence supports a role for the renin-angiotensin-aldosterone system (RAAS) as a determinant of cardiac dysfunction. In this regard, blockers of the RAAS improve outcomes in heart failure with a reduced ejection fraction (EF). 1,2 In contrast, however, RAAS blockers have provided disappointing results in heart failure with a preserved EF, 3-10 a form of heart failure characterized by cardiac diastolic dysfunction. [11] [12] [13] This is despite the well-recognized contribution of the RAAS to left ventricular (LV) hypertrophy (LVH) and fibrosis, 14-18 changes which in-part mediate LV diastolic dysfunction. 16, [19] [20] [21] However, because LV diastolic function is governed by several mechanisms other than LVH and fibrosis, 22, 23 activation of the RAAS may not explain LV diastolic dysfunction and ultimately heart failure with a preserved EF in all patients. Under these circumstances, it may be important to identify aspects of RAAS activation that contribute to cardiac diastolic dysfunction. In this regard, the role of the systemic RAAS is controversial.
INTRODUCTION
Extensive evidence supports a role for the renin-angiotensin-aldosterone system (RAAS) as a determinant of cardiac dysfunction. In this regard, blockers of the RAAS improve outcomes in heart failure with a reduced ejection fraction (EF). 1, 2 In contrast, however, RAAS blockers have provided disappointing results in heart failure with a preserved EF, [3] [4] [5] [6] [7] [8] [9] [10] a form of heart failure characterized by cardiac diastolic dysfunction. [11] [12] [13] This is despite the well-recognized contribution of the RAAS to left ventricular (LV) hypertrophy (LVH) and fibrosis, [14] [15] [16] [17] [18] changes which in-part mediate LV diastolic dysfunction. 16, [19] [20] [21] However, because LV diastolic function is governed by several mechanisms other than LVH and fibrosis, 22, 23 activation of the RAAS may not explain LV diastolic dysfunction and ultimately heart failure with a preserved EF in all patients. Under these circumstances, it may be important to identify aspects of RAAS activation that contribute to cardiac diastolic dysfunction. In this regard, the role of the systemic RAAS is controversial.
Several studies evaluating associations between plasma renin activity or circulating aldosterone concentrations and LV diastolic function have produced contrasting findings. [24] [25] [26] [27] [28] [29] [30] Importantly, most of these studies have been conducted in small study samples (n = 42-119), [25] [26] [27] [28] [29] did not adjust for blood pressure (BP), 25, 26, 28 or demonstrated a relationship which was eliminated with adjustments for confounders. 24 Hence, the role of circulating renin, and aldosterone as determinants of LV diastolic function is uncertain. As circulating angiotensinogen (AGT) concentrations may approximate the Michaelis-Menten constant (Km) for renin, cleavage of AGT into angiotensin I is thought to be a rate-limiting step in RAAS activation. 31 It is therefore possible that in the presence of lower renin concentrations (such as occurs when BP increases) circulating AGT concentrations may maintain RAAS activation. In this way AGT and hence the RAAS may contribute to LV diastolic function in either high or low renin states. Indeed, suppression of circulating AGT concentrations using chronic antisense therapy targeting hepatic AGT production decreases LVH and Systemic Angiotensinogen Concentrations Are Independently Associated With Left Ventricular Diastolic Function in a Community Sample Aletta M.E. Millen, 1 Angela J. Woodiwiss, 1 Monica Gomes, 1 Frederic Michel, 1 and Gavin R Norton 1 BACKGROUND Left ventricular (LV) diastolic dysfunction characterizes heart failure with a preserved ejection fraction. Although it is recognized that the renin-angiotensin-aldosterone system (RAAS) decreases LV diastolic function, whether systemic angiotensinogen (AGT) contributes to these effects is uncertain. Hence, the aim was to determine the relationship between systemic AGT concentrations and LV diastolic function.
METHODS
LV diastolic function was determined from the mean of the lateral and septal wall myocardial tissue lengthening at the mitral annulus (average e') and from the ratio of early transmitral blood flow velocity (E) to average e' (E/e') in 445 Black African participants from a community sample.
RESULTS
In multivariate regression models with adjustments for age, sex, waist circumference diabetes mellitus, alcohol and tobacco use, hypertension treatment, systolic blood pressure (BP), and relative wall thickness, the square root of serum AGT concentrations was independently associated with E/e' (partial r (95% confidence interval [CI]) = 0.11 (0.02-0.21), P = 0.04), but not with average e' (partial r (95% CI) = −0.06 (−0.15 to 0.04), P = 0.25). There was no association between plasma renin concentrations and markers of diastolic function (all P > 0.05).
myocardial fibrosis in hypertensive rats. 32 However, whether circulating AGT concentrations associate with LV diastolic function in humans has not been determined. Hence, in the present study, we aimed to determine the association between circulating AGT concentrations and diastolic function, independent of BP and additional confounders and whether any relationships noted were dependent on plasma renin concentrations.
METHODS

Participants
Participants older than 16 years were randomly recruited from nuclear families of Black African descent from the South West Township of Johannesburg, South Africa (SOWETO) as previously described. [33] [34] [35] All participants gave written informed consent. The present study was approved by the University of the Witwatersrand Committee for Research in Human Subjects (approval number M02-04-72 renewed as M07-04-69 and M12-04-108). Of the 947 participants who had echocardiography, myocardial diastolic function measures were obtained by tissue Doppler imagining in a substudy conducted in 445 participants.
Clinical, demographic, and anthropometric measurements
Demographic and clinical data were attained from a standardized questionnaire as previously described. [33] [34] [35] Standard anthropometric measures including height, weight, and waist circumference were measured. Participants were identified as being overweight if their body mass index was ≥25 kg/m 2 or obese if their body mass index was ≥30 kg/m 2 . Nurse-derived conventional BP was measured using a mercury sphygmomanometer after 5 minutes of rest in the seated position as previously described. 35 Five consecutive BP readings were obtained using an appropriately sized cuff, 30 to 60 seconds apart. The average of the 5 readings was taken as the BP. Hypertension was defined as the use of antihypertensive medication or if the mean of the 5 conventional BP measurements was >140/90 mm Hg in those not receiving medication. Laboratory blood tests of hematological parameters and percentage glycated hemoglobin (HbA 1C ) were performed. Diabetes mellitus or abnormal blood glucose control was defined as the use of insulin or oral hypoglycemic agents or a glycated hemoglobin (Roche Diagnostics, Mannheim, Germany) value greater than 6.1%.
Plasma renin and AGT concentrations
Blood samples were obtained between 10:00 am and 12:00 pm in the supine position after 10 minutes of rest. Participants were allowed to continue taking all routine medications at the time. After centrifugation samples were stored at −80 °C until analysis. Plasma renin concentrations were measured using an immunoradiometric technique (Renin III Generation, Cisbio International, Ceze, France) with intra-assay coefficients of variation ranging from 1.1% for high concentrations to 4.5% for low concentrations and with a mean interassay coefficient of variation of 5.3%. Plasma AGT concentration was measured using a solid phase sandwich ELISA (IBL, Japan) (range 0.31-20 ng/ml) with an intra-assay and interassay coefficients of variation ranging from 4.4% to 5.5% and 1.5% to 5.8%, respectively.
Echocardiography
Echocardiographic measurements were performed using a Sonosite M-Turbo ultrasound (SonoSite, Bothell, WA) device with the participants in the partial left decubitus position. All potential participants were assessed for mitral valve abnormalities as determined using 2-dimensional and color Doppler imaging and excluded if significant valve abnormalities were present. LV dimensions were determined using 2-dimensional directed M-mode echocardiography in the short axis view according to the American Society of Echocardiography convention. 36 The LV dimensions were measured only when appropriate visualization of both the right and the left septal surfaces occurred and where the endocardial surfaces of both the septal and posterior wall were clearly visible. LV mass (LVM) was determined using a standard formula 37 and indexed (LVMI) to height 2.7 . An LVMI >51 g/m 2.7 was considered to be increased. 38 LV end diastolic and systolic volumes were determined using the Teichholz method. 39 LV EF was calculated as [(LV end diastolic volume − LV end systolic volume)/LV end diastolic volume] × 100.
LV diastolic function was assessed from a pulsed wave Doppler examination of the mitral inflow at rest and using tissue Doppler indices. 40 In the apical 4-chamber view, the sample volume was placed at the tip of the mitral valve leaflet to obtain pulse wave Doppler recordings of transmitral velocity. Transmitral velocity measurements were obtained during the early (E) and late (atrial-A) period of LV diastolic inflow and expressed as E/A ratio. To perform tissue Doppler indices, the sample volume was positioned at the septal and lateral corners of the mitral annulus in the apical 4-chamber view to measure the velocity of myocardial tissue lengthening. To determine diastolic function using tissue Doppler indices, peak velocities during early (e'), and late (atrial) (a') diastole were measured and the mean of septal and lateral wall values calculated. Data were expressed as the E/e' ratio (an index of LV filling pressures). In those participants with an EF <50%, mild LV diastolic dysfunction was identified if the E/A ratio ≤0.8 and E/e' ≤14 and moderateto-severe diastolic dysfunction was identified when E/A ≤0.8 or E/A ≥2 and E/e' >14. In those participants with an EF >50%, LV diastolic dysfunction was identified when lateral e' <10 cm/s or septal e' <7 cm/s or E/e'>14 40 . Those participants where just one of the abovementioned criteria were positive, the E/A ratio was considered to further classify diastolic dysfunction. If only one of the 3 criteria were positive and the E/A was ≤0.8 or ≥2, they were considered to have mild DD or moderate DD, respectively. If they had only one of the criteria positive and E/A was between 0.8 and 2, they were considered to have indeterminate DD. If 2 or more of the criteria were positive they were considered to have moderate diastolic dysfunction if E/A as <2 but severe DD if E/A ≥2. 40 
Statistical analysis
Database management and statistical analyses were performed with SAS software, version 9.4 (SAS Institute, Cary, NC). Data are presented as mean (SD) for normally distributed variables, median (interquartile range) for skewed variables or proportions for categorical variables. Multiple linear regression analysis was performed to assess the relationship between circulating renin and AGT concentrations and markers of diastolic function. As the present study was performed on a community sample consisting of largely healthy adults, only 4% of participants had an EF<50%. Hence, relationships between RAAS concentrations and E/e' and average e' , but not E/A were sought. In this regard, E/A is only employed to detect diastolic dysfunction in those with a reduced EF. 40 Due to comparisons being made with more than one outcome variable, P values were adjusted according to the false discovery rate (FDR) method 41 in order to reduce the possibility of a type I error. As we have previously reported, systolic BP (SBP) is more closely related to E/e' , 33 systolic BP was employed in all models. The following additional parameters were included in the regression models based on bivariate associations with LV diastolic function (data not shown): age, gender, regular alcohol or tobacco use, the presence or absence of diabetes mellitus or inappropriate blood glucose control (considered as a single covariate) the use of antihypertensive agents and heart rate. In secondary analysis LVMI and relative wall thickness (RWT) was also included in the regression models. To compare the relative impact of circulating AGT concentrations on indexes of diastolic function, standardized β-coefficients were determined. To determine the association between AGT concentrations and diastolic dysfunction, multivariate logistic regression analysis was performed. Further variables were introduced into the logistic regression models as standardized variables in order to determine the impact of a 1 SD increase in independent variables on the development of diastolic dysfunction. As the distribution of a number of variables deviated from normal, these values were logarithmically transformed (renin, E/e' , and average e') or expressed as a square root (AGT) in order to improve skewness and kurtosis. Table 1 shows the demographic and clinical characteristics of the sample that had plasma AGT (n = 445) concentrations and those who had plasma renin and AGT concentrations (n = 364) determined. The majority of participants were women and a large proportion of the participants were overweight or obese. The study sample did not differ in essential characteristics from the sample without tissue Doppler imaging except for modestly higher BP values (Supplementary  Table S1 ). Moreover, those who had plasma renin and AGT concentrations determined did not differ in their essential characteristics from those without both plasma renin and AGT concentrations (Supplementary Table S2 ). Abbreviations: AGT, angiotensinogen concentrations; DBP, diastolic BP; E/A, ratio of transmitral early-to-atrial (late) blood flow velocity; E/e', E/velocity of the mean value of lateral and septal wall myocardial tissue lengthening in early diastole at the mitral annulus; SBP, systolic blood pressure.
RESULTS
Characteristics of the participants
Of the sample, 43% had hypertension and 27% were receiving treatment for their hypertension. Only one participant had an EF <40%, 4% had an EF <50% and 20% of the sample had LVH (LVMI > 51 g/m 2.7 ). Of the sample, 15% had mild LV diastolic dysfunction and 7% had moderate-tosevere diastolic dysfunction, while 24% had an indeterminate diastolic function.
The sample had a median (interquartile range) plasma renin concentration of 15.0 pg/ml (6.6-36.3) and a median (interquartile range) plasma AGT concentration of 30.3 µM/l (23.6-38.4). The average AGT concentration was higher in women than in men (38.3 ± 22.9 vs. 33.1 ± 9.7, P = 0.03) and higher in younger as compared to older individuals (37.4 ± 24.6 vs. 35.3 ± 18.8, P < 0.0001).
Relationships between circulating AGT concentrations and indices of LV diastolic function
On multivariate regression analysis, with adjustments for conventional risk factors, including BP and either LVMI or RWT in the models, no relationship was noted between AGT concentrations and the average of lateral and septal e' (Table 2 ). However, in multivariate regression analysis, circulating AGT concentrations were independently associated with log E/e' when adjusting for conventional risk factors and RWT (Table 2) . Plasma AGT concentrations increased across quartiles of E/e' (Figure 1 ) and were higher for quartile 3 and 4 as compared to quartile 2, but was not significantly different for average e' (Figure 1) .
With age, systolic BP, alcohol use, waist circumference, and LVMI or RWT included in the regression model, the impact of AGT concentrations on log E/e' was quantitatively similar to that of several alternative risk factors for increases in E/e' (Supplementary Table S3 ). In the sample of those participants who had both plasma AGT and renin concentrations determined, an independent relationship between AGT concentrations and E/e' and average e' was also noted (Table 3) . When additionally adding renin as a confounder in the fully adjusted multivariate regression models, the relationship between AGT concentration and E/e' (partial r (95% confidence interval [CI]) = 0.11 (0.01-0.21), FDR adjusted P = 0.04) and average e' (partial r (95% CI) = −0.12, (−0.22 to −0.01), FDR adjusted P = 0.04) remained significant.
Relationship between circulating renin concentrations and indexes of LV diastolic function
On multivariate regression analysis, with adjustments for conventional risk factors, including BP and either LVMI or RWT in the models, no relationship was noted between renin concentrations and average e' or E/e' ( Table 3) .
Relationships between circulating AGT concentrations and LV diastolic dysfunction
On multivariate logistic regression analysis, circulating AGT concentrations were not associated with either mild or moderate-to-severe diastolic dysfunction (Supplementary  Table S4 ). However, a 1-SD increase in age, DBP, and heart rate were independently associated with an increased risk of developing mild diastolic dysfunction and age and waist circumference were independently associated with moderateto-severe diastolic dysfunction. Further, a 1-SD increase in age, waist circumference, systolic BP, and heart rate were all associated with an increased risk of developing any diastolic dysfunction.
DISCUSSION
The main finding of the current study is that in a relatively large, randomly selected community-based sample of African ancestry circulating plasma AGT, but not renin concentrations were associated with LV diastolic function, independent of RWT, BP, and several additional confounders. In this regard, circulating AGT concentrations were independently associated with E/e' , an index of LV filling pressures, but not with e' as an index of LV relaxation. Although many studies have reported on relations between other circulating RAAS markers and cardiac diastolic function, to the best of our knowledge this is the first study to report on an independent association between circulating AGT concentrations and diastolic function.
Despite considerable evidence to suggest a major role of the tissue RAAS in mediating cardiac pathology, evidence to support a role of circulating AGT in contributing to cardiac structure and function is limited. In this regard Makino et al. demonstrated that suppression of circulating AGT concentrations and the subsequent decrease in circulating angiotensin II concentrations, using chronic antisense therapy targeting hepatic AGT production, reduced myocardial collagen concentrations and LVM. 32 However, these authors Abbreviations: CI, confidence interval; FDR, false discovery rate; LVMI, left ventricular mass index; RWT, relative wall thickness; SBP, systolic blood pressure; Sqrt AGT, square root of circulating angiotensinogen concentrations.
*Adjustors include age, sex, alcohol, smoking, waist circumference, treatment for hypertension, diabetes mellitus or an abnormal blood glucose control (HbA 1c > 6.1%), and heart rate.
† FDR adjusted P values.
also reported on changes in BP which may have explained these cardiac effects. As both myocardial collagen concentrations and LVH contribute toward LV diastolic function, it is possible that circulating AGT may also decrease diastolic LV function, but through an effect mediated by BP. However, Makino et al. failed to report on the impact of reductions in circulating AGT on LV diastolic function and hence whether changes in myocardial collagen and the extent of LVH in that study translated into DD is uncertain. 32 The present study suggests that circulating AGT may indeed contribute toward diastolic LV function, but that this is largely independent of indices of LV structural remodeling and more importantly is also independent of BP. Whether the relationship between circulating AGT concentrations and LV diastolic function in the present study can be explained by differences in myocardial collagen concentrations, nevertheless requires further evaluation.
The question arises as to whether relations between circulating AGT concentrations and diastolic function are influenced by circulating renin. In this regard, a previous study has reported that renin inhibition in vitro and in vivo attenuates myocardial fibrosis, but did not assess the impact of renin inhibition on LV diastolic function. 42 An inverse association between plasma renin activity and diastolic function has nevertheless been reported. 26 However, in that study, 26 a small sample size (n = 63) was employed and the authors reported bivariate correlations between plasma renin and indices of LV diastolic function, without adjusting for confounders, such as BP. In contrast, in agreement with the majority of previous studies, 24, 25, [27] [28] [29] we failed to show associations between plasma renin concentrations and LV diastolic function. Moreover, our results demonstrate that the independent association between circulating AGT concentrations and LV diastolic function are not influenced by adjustments for renin concentrations. Thus, higher AGT concentrations may influence diastolic function at low or high plasma renin concentrations.
Decreases in myocardial collagen concentrations following suppression of circulating AGT concentrations using chronic antisense therapy targeting hepatic AGT production, may have occurred through the downstream effects of angiotensin II or the subsequent impact on aldosterone synthesis. 32 In this regard, angiotensin II is a growth-promoting factor that is directly involved in collagen synthesis in the heart, but may also produce its effects through the impact of aldosterone. [43] [44] [45] In human studies, associations between circulating angiotensin II or aldosterone concentrations and LV diastolic function have been conflicting. [24] [25] [26] [27] [28] [29] [30] In this Figure 1 . Multivariate adjusted AGT concentrations across quartiles of diastolic function measures. Adjustments are for age, sex smoking, alcohol use, waist circumference, treatment for hypertension, the presence of diabetes mellitus or an HbA 1C >6.1% heart rate, SBP, and LVM indexed to height 2.7 . P values were adjusted for multiple tests according to the False Discovery Rate method. *P < 0.02 vs. Q2, † P < 0.05 vs. Q2. Abbreviations: ave, average; LVM, left ventricular mass; Q, quartile; SBP, systolic blood pressure; SQRT AGT, square root of angiotensinogen concentration. regard some, 24, 26, 27, 29 but not other 25, 28, 30 studies have shown an association between circulating plasma aldosterone concentrations and markers of diastolic function. However, thus far, despite the reported association between angiotensin II and collagen synthesis [41] [42] [43] no association between angiotensin II concentrations and LV diastolic function has been reported in humans. 28, 29 Hence, the evidence best supports a notion that the circulating RAAS, possibly through an impact of enhanced circulating AGT, may mediate changes in diastolic function via the effects of aldosterone, rather than through the impact of angiotensin II. In this regard, further studies are warranted to explore the possibility that relations between circulating AGT concentrations and LV diastolic function are accounted for by alterations in circulating aldosterone concentrations. Gene polymorphisms which may influence circulating concentrations of AGT 46, 47 have been associated with LVH 48 and as highlighted in previous discussion, LVH is a well-recognized structural change associated with DD. The question therefore arises as to whether the AGT-diastolic function relationship noted in the present study can be attributed to LVH or LV structural remodeling? However, we show that the relationship between circulating AGT concentrations and LV diastolic function was largely independent of indices of LV structural remodeling. It is therefore possible that any cause-effect relationship between circulating AGT concentrations and E/e' that may exist could be explained by direct effects of the RAAS driven by increased AGT, on the myocardium, rather than through structural remodeling of the LV.
AGT gene variants which influence circulating concentrations of AGT 46, 47 are also associated with an increased risk for the development of heart failure. 49 In this regard, if the development of heart failure is in-part mediated by the effects of AGT gene variants, the present data suggests that this may be caused by the impact of circulating AGT concentrations on LV diastolic function. However, whether circulating AGT concentrations or the gene variants that determine these concentrations, promote the development heart failure with a preserved rather than reduced EF, requires further study.
Of importance, an apparent discrepancy in the present study is that our results showed an association between circulating AGT concentrations and E/e' , but not with e' . In this regard, it is well known that cardiac diastolic function is driven by active (energy requiring) processes that promote relaxation of the heart and passive process involving changes in the characteristics of the interstitium (increased expression and enhanced cross-linking of collagen) and cardiomyocytes (alterations in myocardial titin expression) that mediate increases in stiffness of the myocardium. 23 It is possible that decreases in e' may reflect impaired relaxation and reductions in active calcium dependent mechanisms, whereas E/e' , being an index of filling pressures, is more dependent on alterations in passive processes such as fibrosis. Indeed, myocardial fibrosis is correlated more strongly with E/e' than with markers of relaxation. 50 Hence, the relationships between AGT concentrations and E/e' , but not e' may reflect an impact of the RAAS on myocardial passive and not active relaxation processes, a finding consistent with the well-known effect of the RAAS on fibrosis.
Despite an independent association with LV diastolic function observed in the present study (as determined by the E/e'), circulating AGT concentrations were not associated with LV diastolic dysfunction. The lack of association between AGT concentrations and diastolic dysfunction can possibly be explained by the low proportion of persons classified with DD in this sample. Indeed, in persons with an EF >50% DD is only classified when E/e' >14 40 and being a community-based study, only a small proportion of the sample had diastolic dysfunction according to this classification. Furthermore, E/A is only considered as a criterion for DD in those with an EF <50%, which only occurred in 4% of our sample. Hence, the small proportion of persons with DD resulted in inadequate statistical power to show this relationship and hence further longitudinal studies are required to demonstrate a relationship between circulating AGT concentrations and the development of LV diastolic dysfunction.
There are several limitations to the present study that require consideration. First, this is a cross-sectional study and hence no conclusions can be drawn on cause and effect. Second, more women than men volunteered for the present study and the population had a high prevalence of overweight and obesity. In this regard, we did not have a sufficiently large sample to perform sensitivity analysis in men and women separately and in lean versus obese individuals. Hence, the results may be relevant to women and obese or overweight individuals only. Third, measurements of active plasma renin concentrations were not available in all of the participants who had measurements of plasma AGT concentrations. Despite the smaller sample of those participants with circulating renin and AGT measurements, we were still statistically powered to show relationships between AGT concentrations and LV diastolic function in the smaller sample. Last, the sample is representative of persons of African ancestry, and as it is well known that renal mechanisms of salt handling and thus the RAAS are different in groups of African as compared to European ancestry, the results may only apply to persons of African ancestry. Further investigations are therefore required to confirm the AGT-E/e' relationship in other ethnic groups.
In conclusion, in the current study we show that in a community sample of African ancestry circulating AGT concentrations are independently associated with aspects (E/e') of LV diastolic function. Importantly, this association is independent of BP load as well as cardiac structural remodeling. Whether circulating AGT concentrations predict the risk of developing heart failure with a preserved EF, a form of heart failure characterized by diastolic dysfunction, or may be employed to identify those patients with heart failure with a preserved EF that may benefit from RAAS blockade requires further study.
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